Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Will the Biden administration ‘follow the science’ on regulatory reform?

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations


Corresponding author

Correspondence to John J. Cohrssen.

Ethics declarations

Competing interests

J.J.C. served in senior positions for White House agencies, including as Counsel to the White House Working Group that prepared the 1986 Coordinated Framework for the Regulation of Biotechnology, and is in private legal practice. H.I.M. was the founding director of the FDA’s Office of Biotechnology and is a senior fellow at the Pacific Research Institute.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cohrssen, J.J., Miller, H.I. Will the Biden administration ‘follow the science’ on regulatory reform?. Nat Biotechnol 39, 1334–1335 (2021).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research